BAMCO Inc’s AbbVie ABBV Stock Holding History

BAMCO Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,000	Closed	-$1.74M	–	346
2026 Q1	$1.74M	Sell	8,000 -16,800	-68%	-$3.73M	0.01%	281
2025 Q4	$5.67M	Buy	24,800 +3,800	+18%	+$866K	0.02%	246
2025 Q3	$4.86M	Buy	+21,000	New	+$4.28M	0.01%	257
2023 Q2	–	Sell	-15,000	Closed	-$2.39M	–	344
2023 Q1	$2.39M	Sell	15,000 -25,400	-63%	-$3.88M	0.01%	294
2022 Q4	$6.53M	Sell	40,400 -7,700	-16%	-$1.18M	0.02%	254
2022 Q3	$6.46M	Buy	48,100 +3,500	+8%	+$502K	0.02%	256
2022 Q2	$6.83M	Buy	44,600 +14,000	+46%	+$2.14M	0.02%	268
2022 Q1	$4.96M	Buy	+30,600	New	+$4.44M	0.01%	306
2019 Q1	–	Sell	-754	Closed	-$70K	–	357
2018 Q4	$70K	Hold	754	–	–	﹤0.01%	346
2018 Q3	$71K	Hold	754	–	–	﹤0.01%	345
2018 Q2	$70K	Buy	754 +73	+11%	+$7.13K	﹤0.01%	341
2018 Q1	$64K	Buy	+681	New	+$74.8K	﹤0.01%	327

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BAMCO Inc's ABBV Position: Q2 2026 in Review

BAMCO Inc sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 8,000 shares — an estimated $1.74M sold.

BAMCO Inc first reported a position in ABBV in Q1 2018 and held it in 12 quarters. The position peaked at $6.83M in Q2 2022. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BAMCO Inc reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
BAMCO Inc sold 8,000 AbbVie shares in Q2 2026, an estimated $1.74M.
BAMCO Inc first reported a position in AbbVie in Q1 2018 and held it in 12 quarters.
BAMCO Inc's AbbVie position peaked at $6.83M in Q2 2022.
4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.